Angelika Joos

Executive Director, Science & Regulatory Policy MSD

Angelika Joos is a trained pharmacist. She is responsible for International Regulatory & Clinical Policy issues within MSD’s Global Regulatory Affairs and Clinical Safety department. This role includes identifying regulatory policy priorities that align with MSD’s business priorities, leading cross-functional networks to define policy positions, and informing MSD’s regulatory strategy development.

Angelika represents MSD in the IFPMA Regulatory Science Committee and is one of IFPMA’s delegates to the ICH Management Committee. She is also involved in international policy activities though EFPIA as well as the BIO and the PhRMA international committees.

See Angelika Joos at this event

Webinar 4 Tuesday 25 November

Streamlining regulatory and ethics approvals

13:00 - 13:55 CET

Research capacity activities in clinical trials

Caxton Murira, Science for Africa Foundation

Reliance in clinical trials

Lada Leyens, Takeda on behalf of IFPMA

A digital platform for clinical trial approval

Adriaan Kruger & Marina Lazaridis, nuvoteQ Foundation

Moderated Panel Session

Kwasi Nyarko, AVAREF
David Mukanga, Gates Foundation
Elvis Temfack, Africa CDC
Caroline Macharia, J&J
Angelika Joos, MSD on behalf of IFPMA
Keymanthri Moodley, Emeritus Professor – Stellenbosch University, SA & Adjunct Professor, University of North Carolina-Chapel Hill, USA

Speakers

Speakers